SlideShare une entreprise Scribd logo

Open Data In Clinical Research

•
•
Martin Fenner
Martin Fenner
BusinessSanté & Médecine
1  sur  7
Télécharger pour lire hors ligne
Clinical trial registration: a model for basic research? August 17, 2008 Version 1.0 Martin Fenner fenner.martin@mh-hannover.de Hannover Medical School, Germany
Rationale for registration of clinical trials • Improve trial participation by patients • Reduce unnecessary duplication of research efforts • Increase opportunities for collaboration • Prevent biased under-reporting or over-reporting of research Krleza-Jeric 2005. doi:10.1136/bmj.330.7497.956
Open Data In Clinical Research
Open Data In Clinical Research
Open Data In Clinical Research
Open Data In Clinical Research
Open Data In Clinical Research

Recommandé

Safety Data Exchange Agreements (Brief)
Safety Data Exchange Agreements (Brief)Safety Data Exchange Agreements (Brief)
Safety Data Exchange Agreements (Brief)Arete-Zoe, LLC
 
GXP Inspection readiness
GXP Inspection readinessGXP Inspection readiness
GXP Inspection readinessArete-Zoe, LLC
 
Stem cells: Information environment
Stem cells: Information environmentStem cells: Information environment
Stem cells: Information environmentArete-Zoe, LLC
 
Ich
IchIch
IchMalla Reddy College of Pharmacy
 
ICSR Narrative Writing_Katalyst HLS
ICSR Narrative Writing_Katalyst HLSICSR Narrative Writing_Katalyst HLS
ICSR Narrative Writing_Katalyst HLSKatalyst HLS
 
ICH GUIDELINES Q S E M & REGULATORY REQUIREMENTS OF EU, MHRA, TGA & ROW CO...
ICH GUIDELINES Q S E M & REGULATORY REQUIREMENTS OF EU, MHRA, TGA & ROW CO...ICH GUIDELINES Q S E M & REGULATORY REQUIREMENTS OF EU, MHRA, TGA & ROW CO...
ICH GUIDELINES Q S E M & REGULATORY REQUIREMENTS OF EU, MHRA, TGA & ROW CO...RushikeshPalkar1
 
Controlled release drug delivery market offers unexplored opportunities
Controlled release drug delivery market offers unexplored opportunitiesControlled release drug delivery market offers unexplored opportunities
Controlled release drug delivery market offers unexplored opportunitiesKuicK Research
 
Analysing the EU PVG regulations
Analysing the EU PVG regulationsAnalysing the EU PVG regulations
Analysing the EU PVG regulationsUntil ROI
 

Recommandé

Safety Data Exchange Agreements (Brief)
Safety Data Exchange Agreements (Brief)Safety Data Exchange Agreements (Brief)
Safety Data Exchange Agreements (Brief)Arete-Zoe, LLC
 
GXP Inspection readiness
GXP Inspection readinessGXP Inspection readiness
GXP Inspection readinessArete-Zoe, LLC
 
Stem cells: Information environment
Stem cells: Information environmentStem cells: Information environment
Stem cells: Information environmentArete-Zoe, LLC
 
Ich
IchIch
IchMalla Reddy College of Pharmacy
 
ICSR Narrative Writing_Katalyst HLS
ICSR Narrative Writing_Katalyst HLSICSR Narrative Writing_Katalyst HLS
ICSR Narrative Writing_Katalyst HLSKatalyst HLS
 
ICH GUIDELINES Q S E M & REGULATORY REQUIREMENTS OF EU, MHRA, TGA & ROW CO...
ICH GUIDELINES Q S E M & REGULATORY REQUIREMENTS OF EU, MHRA, TGA & ROW CO...ICH GUIDELINES Q S E M & REGULATORY REQUIREMENTS OF EU, MHRA, TGA & ROW CO...
ICH GUIDELINES Q S E M & REGULATORY REQUIREMENTS OF EU, MHRA, TGA & ROW CO...RushikeshPalkar1
 
Controlled release drug delivery market offers unexplored opportunities
Controlled release drug delivery market offers unexplored opportunitiesControlled release drug delivery market offers unexplored opportunities
Controlled release drug delivery market offers unexplored opportunitiesKuicK Research
 
Analysing the EU PVG regulations
Analysing the EU PVG regulationsAnalysing the EU PVG regulations
Analysing the EU PVG regulationsUntil ROI
 
Pharmacovigilance systems & methodologies across the globe
Pharmacovigilance systems & methodologies across the globePharmacovigilance systems & methodologies across the globe
Pharmacovigilance systems & methodologies across the globeILHAR HASHIM
 
Market impact of WHO selection and prequalification of priority medicines
Market impact of WHO selection and prequalification of priority medicinesMarket impact of WHO selection and prequalification of priority medicines
Market impact of WHO selection and prequalification of priority medicinesUNITAID
 
Pharmacovigilance
PharmacovigilancePharmacovigilance
PharmacovigilanceTulasi Raman
 
Pharmacovigilance - a regulator's perspective
Pharmacovigilance - a regulator's perspectivePharmacovigilance - a regulator's perspective
Pharmacovigilance - a regulator's perspectiveTGA Australia
 
Post marketing servillence
Post marketing servillencePost marketing servillence
Post marketing servillencebdvfgbdhg
 
Literature monitoring for pv what are we doing at galderma elsevier webinar
Literature monitoring for pv what are we doing at galderma elsevier webinarLiterature monitoring for pv what are we doing at galderma elsevier webinar
Literature monitoring for pv what are we doing at galderma elsevier webinarAnn-Marie Roche
 
Clinical research and pharmacovigilance biopharmaceutics
Clinical research and pharmacovigilance biopharmaceuticsClinical research and pharmacovigilance biopharmaceutics
Clinical research and pharmacovigilance biopharmaceuticsPrajith V
 
Expectedness/Unexpectedness Assessment_Katalyst HLS
Expectedness/Unexpectedness Assessment_Katalyst HLSExpectedness/Unexpectedness Assessment_Katalyst HLS
Expectedness/Unexpectedness Assessment_Katalyst HLSKatalyst HLS
 
Rajath (1)
Rajath (1)Rajath (1)
Rajath (1)rajath s
 
Outsourcing bioavailibility and bioequivalence studies to contract research
Outsourcing bioavailibility and bioequivalence studies to contract researchOutsourcing bioavailibility and bioequivalence studies to contract research
Outsourcing bioavailibility and bioequivalence studies to contract researchGauravchaudhary199
 
Drug Information Association Clinical Forum Presentation
Drug Information Association Clinical Forum PresentationDrug Information Association Clinical Forum Presentation
Drug Information Association Clinical Forum Presentationdneasha
 
Controlled drug release market to grow exponentially
Controlled drug release market to grow exponentiallyControlled drug release market to grow exponentially
Controlled drug release market to grow exponentiallyKuicK Research
 
Pharmacovigilance
PharmacovigilancePharmacovigilance
PharmacovigilanceJABEEN FATIMA
 
Premarket Clinical Evaluation under the EU MDR proposal
Premarket Clinical Evaluation under the EU MDR proposalPremarket Clinical Evaluation under the EU MDR proposal
Premarket Clinical Evaluation under the EU MDR proposalAnnet Visscher
 
Biologics market
Biologics market Biologics market
Biologics market stephenb65
 
Drug Safety Regulations In The Us And Eu
Drug Safety Regulations In The Us And EuDrug Safety Regulations In The Us And Eu
Drug Safety Regulations In The Us And EuAngelinabarfield
 
pharmacovigilance in india-by dr.nagaraja prasad.s
pharmacovigilance in india-by dr.nagaraja prasad.spharmacovigilance in india-by dr.nagaraja prasad.s
pharmacovigilance in india-by dr.nagaraja prasad.sNagaraja Prasad Sai
 
Post marketing surveilance
Post marketing surveilancePost marketing surveilance
Post marketing surveilanceaiswarya thomas
 
Pharmacovigilance System in Pakistan
Pharmacovigilance System in PakistanPharmacovigilance System in Pakistan
Pharmacovigilance System in PakistanCepal & Co.
 
Post marketing surveillance
Post marketing surveillancePost marketing surveillance
Post marketing surveillancesuraj mungase
 
ONCOPHARMACOECONOMY-I, Prof. Dr. F. Cankat Tulunay
ONCOPHARMACOECONOMY-I, Prof. Dr. F. Cankat TulunayONCOPHARMACOECONOMY-I, Prof. Dr. F. Cankat Tulunay
ONCOPHARMACOECONOMY-I, Prof. Dr. F. Cankat TulunayF. Cankat Tulunay
 
ICH GCP
ICH GCPICH GCP
ICH GCPTamer Hifnawy
 

Contenu connexe

Tendances

Pharmacovigilance systems & methodologies across the globe
Pharmacovigilance systems & methodologies across the globePharmacovigilance systems & methodologies across the globe
Pharmacovigilance systems & methodologies across the globeILHAR HASHIM
 
Market impact of WHO selection and prequalification of priority medicines
Market impact of WHO selection and prequalification of priority medicinesMarket impact of WHO selection and prequalification of priority medicines
Market impact of WHO selection and prequalification of priority medicinesUNITAID
 
Pharmacovigilance - a regulator's perspective
Pharmacovigilance - a regulator's perspectivePharmacovigilance - a regulator's perspective
Pharmacovigilance - a regulator's perspectiveTGA Australia
 
Post marketing servillence
Post marketing servillencePost marketing servillence
Post marketing servillencebdvfgbdhg
 
Literature monitoring for pv what are we doing at galderma elsevier webinar
Literature monitoring for pv what are we doing at galderma elsevier webinarLiterature monitoring for pv what are we doing at galderma elsevier webinar
Literature monitoring for pv what are we doing at galderma elsevier webinarAnn-Marie Roche
 
Clinical research and pharmacovigilance biopharmaceutics
Clinical research and pharmacovigilance biopharmaceuticsClinical research and pharmacovigilance biopharmaceutics
Clinical research and pharmacovigilance biopharmaceuticsPrajith V
 
Expectedness/Unexpectedness Assessment_Katalyst HLS
Expectedness/Unexpectedness Assessment_Katalyst HLSExpectedness/Unexpectedness Assessment_Katalyst HLS
Expectedness/Unexpectedness Assessment_Katalyst HLSKatalyst HLS
 
Rajath (1)
Rajath (1)Rajath (1)
Rajath (1)rajath s
 
Outsourcing bioavailibility and bioequivalence studies to contract research
Outsourcing bioavailibility and bioequivalence studies to contract researchOutsourcing bioavailibility and bioequivalence studies to contract research
Outsourcing bioavailibility and bioequivalence studies to contract researchGauravchaudhary199
 
Drug Information Association Clinical Forum Presentation
Drug Information Association Clinical Forum PresentationDrug Information Association Clinical Forum Presentation
Drug Information Association Clinical Forum Presentationdneasha
 
Controlled drug release market to grow exponentially
Controlled drug release market to grow exponentiallyControlled drug release market to grow exponentially
Controlled drug release market to grow exponentiallyKuicK Research
 
Premarket Clinical Evaluation under the EU MDR proposal
Premarket Clinical Evaluation under the EU MDR proposalPremarket Clinical Evaluation under the EU MDR proposal
Premarket Clinical Evaluation under the EU MDR proposalAnnet Visscher
 
Biologics market
Biologics market Biologics market
Biologics market stephenb65
 
Drug Safety Regulations In The Us And Eu
Drug Safety Regulations In The Us And EuDrug Safety Regulations In The Us And Eu
Drug Safety Regulations In The Us And EuAngelinabarfield
 
pharmacovigilance in india-by dr.nagaraja prasad.s
pharmacovigilance in india-by dr.nagaraja prasad.spharmacovigilance in india-by dr.nagaraja prasad.s
pharmacovigilance in india-by dr.nagaraja prasad.sNagaraja Prasad Sai
 
Post marketing surveilance
Post marketing surveilancePost marketing surveilance
Post marketing surveilanceaiswarya thomas
 
Pharmacovigilance System in Pakistan
Pharmacovigilance System in PakistanPharmacovigilance System in Pakistan
Pharmacovigilance System in PakistanCepal & Co.
 
Post marketing surveillance
Post marketing surveillancePost marketing surveillance
Post marketing surveillancesuraj mungase
 

Tendances (20)

Pharmacovigilance systems & methodologies across the globe
Pharmacovigilance systems & methodologies across the globePharmacovigilance systems & methodologies across the globe
Pharmacovigilance systems & methodologies across the globe
 
Market impact of WHO selection and prequalification of priority medicines
Market impact of WHO selection and prequalification of priority medicinesMarket impact of WHO selection and prequalification of priority medicines
Market impact of WHO selection and prequalification of priority medicines
 
Pharmacovigilance
PharmacovigilancePharmacovigilance
Pharmacovigilance
 
Pharmacovigilance - a regulator's perspective
Pharmacovigilance - a regulator's perspectivePharmacovigilance - a regulator's perspective
Pharmacovigilance - a regulator's perspective
 
Post marketing servillence
Post marketing servillencePost marketing servillence
Post marketing servillence
 
Literature monitoring for pv what are we doing at galderma elsevier webinar
Literature monitoring for pv what are we doing at galderma elsevier webinarLiterature monitoring for pv what are we doing at galderma elsevier webinar
Literature monitoring for pv what are we doing at galderma elsevier webinar
 
Clinical research and pharmacovigilance biopharmaceutics
Clinical research and pharmacovigilance biopharmaceuticsClinical research and pharmacovigilance biopharmaceutics
Clinical research and pharmacovigilance biopharmaceutics
 
Expectedness/Unexpectedness Assessment_Katalyst HLS
Expectedness/Unexpectedness Assessment_Katalyst HLSExpectedness/Unexpectedness Assessment_Katalyst HLS
Expectedness/Unexpectedness Assessment_Katalyst HLS
 
Rajath (1)
Rajath (1)Rajath (1)
Rajath (1)
 
Outsourcing bioavailibility and bioequivalence studies to contract research
Outsourcing bioavailibility and bioequivalence studies to contract researchOutsourcing bioavailibility and bioequivalence studies to contract research
Outsourcing bioavailibility and bioequivalence studies to contract research
 
Drug Information Association Clinical Forum Presentation
Drug Information Association Clinical Forum PresentationDrug Information Association Clinical Forum Presentation
Drug Information Association Clinical Forum Presentation
 
Controlled drug release market to grow exponentially
Controlled drug release market to grow exponentiallyControlled drug release market to grow exponentially
Controlled drug release market to grow exponentially
 
Pharmacovigilance
PharmacovigilancePharmacovigilance
Pharmacovigilance
 
Premarket Clinical Evaluation under the EU MDR proposal
Premarket Clinical Evaluation under the EU MDR proposalPremarket Clinical Evaluation under the EU MDR proposal
Premarket Clinical Evaluation under the EU MDR proposal
 
Biologics market
Biologics market Biologics market
Biologics market
 
Drug Safety Regulations In The Us And Eu
Drug Safety Regulations In The Us And EuDrug Safety Regulations In The Us And Eu
Drug Safety Regulations In The Us And Eu
 
pharmacovigilance in india-by dr.nagaraja prasad.s
pharmacovigilance in india-by dr.nagaraja prasad.spharmacovigilance in india-by dr.nagaraja prasad.s
pharmacovigilance in india-by dr.nagaraja prasad.s
 
Post marketing surveilance
Post marketing surveilancePost marketing surveilance
Post marketing surveilance
 
Pharmacovigilance System in Pakistan
Pharmacovigilance System in PakistanPharmacovigilance System in Pakistan
Pharmacovigilance System in Pakistan
 
Post marketing surveillance
Post marketing surveillancePost marketing surveillance
Post marketing surveillance
 

Similaire à Open Data In Clinical Research

ONCOPHARMACOECONOMY-I, Prof. Dr. F. Cankat Tulunay
ONCOPHARMACOECONOMY-I, Prof. Dr. F. Cankat TulunayONCOPHARMACOECONOMY-I, Prof. Dr. F. Cankat Tulunay
ONCOPHARMACOECONOMY-I, Prof. Dr. F. Cankat TulunayF. Cankat Tulunay
 
MAGI West 2010 Presentation Final
MAGI West 2010 Presentation FinalMAGI West 2010 Presentation Final
MAGI West 2010 Presentation FinalMitko Shoshev
 
Clinical Rubik's Cube: Global Clinical Trials in Hungary
Clinical Rubik's Cube: Global Clinical Trials in HungaryClinical Rubik's Cube: Global Clinical Trials in Hungary
Clinical Rubik's Cube: Global Clinical Trials in HungaryAleksandar Skuban, M.D.
 
Turkiyede klinik arastirma 2015 ing
Turkiyede klinik arastirma 2015 ingTurkiyede klinik arastirma 2015 ing
Turkiyede klinik arastirma 2015 ingtyfngnc
 
Stage IIB carcinoma of the cervix that is associated with pelvic kidney: Athe...
Stage IIB carcinoma of the cervix that is associated with pelvic kidney: Athe...Stage IIB carcinoma of the cervix that is associated with pelvic kidney: Athe...
Stage IIB carcinoma of the cervix that is associated with pelvic kidney: Athe...MedicineAndHealth14
 
PEPTIDES AS BIOTHERAPEUTIC TOOLS PEPTIDES AS BIOTHERAPEUTIC TOOLS
PEPTIDES AS BIOTHERAPEUTIC TOOLS PEPTIDES AS BIOTHERAPEUTIC TOOLSPEPTIDES AS BIOTHERAPEUTIC TOOLS PEPTIDES AS BIOTHERAPEUTIC TOOLS
PEPTIDES AS BIOTHERAPEUTIC TOOLS PEPTIDES AS BIOTHERAPEUTIC TOOLSMedicineAndHealth14
 
2008 global development korea's perspective and the role of kfda
2008 global development korea's perspective and the role of kfda2008 global development korea's perspective and the role of kfda
2008 global development korea's perspective and the role of kfdapatyi_2000
 
Forsythe protocol 2014 summit
Forsythe protocol 2014 summitForsythe protocol 2014 summit
Forsythe protocol 2014 summitTahoe eLab
 
2014 09-10 ACI biomarker utilisation & commercialisation, London
2014 09-10 ACI biomarker utilisation & commercialisation, London2014 09-10 ACI biomarker utilisation & commercialisation, London
2014 09-10 ACI biomarker utilisation & commercialisation, LondonAlain van Gool
 
Highlights from ExL Pharma's 5th Clinical Data Disclosure Summit
Highlights from ExL Pharma's 5th Clinical Data Disclosure SummitHighlights from ExL Pharma's 5th Clinical Data Disclosure Summit
Highlights from ExL Pharma's 5th Clinical Data Disclosure SummitExL Pharma
 
Brian Ager - Selling Sickness 2010
Brian Ager - Selling Sickness 2010Brian Ager - Selling Sickness 2010
Brian Ager - Selling Sickness 2010Gezonde scepsis
 
translational biotechnology-Amgen -Geeta Iyer -4-48-16
translational biotechnology-Amgen -Geeta Iyer -4-48-16translational biotechnology-Amgen -Geeta Iyer -4-48-16
translational biotechnology-Amgen -Geeta Iyer -4-48-16Geeta Iyer
 
Μάκης Παπαταξιάρχης - 6th Clinical Research Conference
Μάκης Παπαταξιάρχης - 6th Clinical Research ConferenceΜάκης Παπαταξιάρχης - 6th Clinical Research Conference
Μάκης Παπαταξιάρχης - 6th Clinical Research ConferenceStarttech Ventures
 
Use of Tumor Markers in Liver, Bladder, Cervical, and Gastric Cancers
Use of Tumor Markers in Liver, Bladder, Cervical, and Gastric CancersUse of Tumor Markers in Liver, Bladder, Cervical, and Gastric Cancers
Use of Tumor Markers in Liver, Bladder, Cervical, and Gastric CancersLAB IDEA
 

Similaire à Open Data In Clinical Research (20)

ONCOPHARMACOECONOMY-I, Prof. Dr. F. Cankat Tulunay
ONCOPHARMACOECONOMY-I, Prof. Dr. F. Cankat TulunayONCOPHARMACOECONOMY-I, Prof. Dr. F. Cankat Tulunay
ONCOPHARMACOECONOMY-I, Prof. Dr. F. Cankat Tulunay
 
ICH GCP
ICH GCPICH GCP
ICH GCP
 
MAGI West 2010 Presentation Final
MAGI West 2010 Presentation FinalMAGI West 2010 Presentation Final
MAGI West 2010 Presentation Final
 
Affitech
AffitechAffitech
Affitech
 
Clinical Rubik's Cube: Global Clinical Trials in Hungary
Clinical Rubik's Cube: Global Clinical Trials in HungaryClinical Rubik's Cube: Global Clinical Trials in Hungary
Clinical Rubik's Cube: Global Clinical Trials in Hungary
 
Turkiyede klinik arastirma 2015 ing
Turkiyede klinik arastirma 2015 ingTurkiyede klinik arastirma 2015 ing
Turkiyede klinik arastirma 2015 ing
 
Stage IIB carcinoma of the cervix that is associated with pelvic kidney: Athe...
Stage IIB carcinoma of the cervix that is associated with pelvic kidney: Athe...Stage IIB carcinoma of the cervix that is associated with pelvic kidney: Athe...
Stage IIB carcinoma of the cervix that is associated with pelvic kidney: Athe...
 
PEPTIDES AS BIOTHERAPEUTIC TOOLS PEPTIDES AS BIOTHERAPEUTIC TOOLS
PEPTIDES AS BIOTHERAPEUTIC TOOLS PEPTIDES AS BIOTHERAPEUTIC TOOLSPEPTIDES AS BIOTHERAPEUTIC TOOLS PEPTIDES AS BIOTHERAPEUTIC TOOLS
PEPTIDES AS BIOTHERAPEUTIC TOOLS PEPTIDES AS BIOTHERAPEUTIC TOOLS
 
Ich
IchIch
Ich
 
Development of Novel Targeted Drugs: Which Target? by Eric Raymond
Development of Novel Targeted Drugs: Which Target? by Eric RaymondDevelopment of Novel Targeted Drugs: Which Target? by Eric Raymond
Development of Novel Targeted Drugs: Which Target? by Eric Raymond
 
Knowledge is Power: ovarian cancer
Knowledge is Power: ovarian cancer Knowledge is Power: ovarian cancer
Knowledge is Power: ovarian cancer
 
2008 global development korea's perspective and the role of kfda
2008 global development korea's perspective and the role of kfda2008 global development korea's perspective and the role of kfda
2008 global development korea's perspective and the role of kfda
 
Forsythe protocol 2014 summit
Forsythe protocol 2014 summitForsythe protocol 2014 summit
Forsythe protocol 2014 summit
 
2014 09-10 ACI biomarker utilisation & commercialisation, London
2014 09-10 ACI biomarker utilisation & commercialisation, London2014 09-10 ACI biomarker utilisation & commercialisation, London
2014 09-10 ACI biomarker utilisation & commercialisation, London
 
Highlights from ExL Pharma's 5th Clinical Data Disclosure Summit
Highlights from ExL Pharma's 5th Clinical Data Disclosure SummitHighlights from ExL Pharma's 5th Clinical Data Disclosure Summit
Highlights from ExL Pharma's 5th Clinical Data Disclosure Summit
 
Presentation from Dr. Alan Lewis
Presentation from Dr. Alan LewisPresentation from Dr. Alan Lewis
Presentation from Dr. Alan Lewis
 
Brian Ager - Selling Sickness 2010
Brian Ager - Selling Sickness 2010Brian Ager - Selling Sickness 2010
Brian Ager - Selling Sickness 2010
 
translational biotechnology-Amgen -Geeta Iyer -4-48-16
translational biotechnology-Amgen -Geeta Iyer -4-48-16translational biotechnology-Amgen -Geeta Iyer -4-48-16
translational biotechnology-Amgen -Geeta Iyer -4-48-16
 
Μάκης Παπαταξιάρχης - 6th Clinical Research Conference
Μάκης Παπαταξιάρχης - 6th Clinical Research ConferenceΜάκης Παπαταξιάρχης - 6th Clinical Research Conference
Μάκης Παπαταξιάρχης - 6th Clinical Research Conference
 
Use of Tumor Markers in Liver, Bladder, Cervical, and Gastric Cancers
Use of Tumor Markers in Liver, Bladder, Cervical, and Gastric CancersUse of Tumor Markers in Liver, Bladder, Cervical, and Gastric Cancers
Use of Tumor Markers in Liver, Bladder, Cervical, and Gastric Cancers
 

Plus de Martin Fenner

Tools for Authors 18.01.11
Tools for Authors 18.01.11Tools for Authors 18.01.11
Tools for Authors 18.01.11Martin Fenner
 
Repositories: Researcher Perspective
Repositories: Researcher PerspectiveRepositories: Researcher Perspective
Repositories: Researcher PerspectiveMartin Fenner
 
ORCID Outreach Working Group
ORCID Outreach Working GroupORCID Outreach Working Group
ORCID Outreach Working GroupMartin Fenner
 
Helping Researchers Create Scholarly Content
Helping Researchers Create Scholarly ContentHelping Researchers Create Scholarly Content
Helping Researchers Create Scholarly ContentMartin Fenner
 
ORCID as unique author identifier: what is it good for and should we worry or...
ORCID as unique author identifier: what is it good for and should we worry or...ORCID as unique author identifier: what is it good for and should we worry or...
ORCID as unique author identifier: what is it good for and should we worry or...Martin Fenner
 
Trends in Reference Management
Trends in Reference ManagementTrends in Reference Management
Trends in Reference ManagementMartin Fenner
 
Open Access In Medicine
Open Access In MedicineOpen Access In Medicine
Open Access In MedicineMartin Fenner
 
Science Publishing - Reward and Reputation
Science Publishing - Reward and ReputationScience Publishing - Reward and Reputation
Science Publishing - Reward and ReputationMartin Fenner
 
What is the right reference manager for you?
What is the right reference manager for you?What is the right reference manager for you?
What is the right reference manager for you?Martin Fenner
 
Providing public health and medical information to all
Providing public health and medical information to allProviding public health and medical information to all
Providing public health and medical information to allMartin Fenner
 

Plus de Martin Fenner (12)

ORCID Principles
ORCID PrinciplesORCID Principles
ORCID Principles
 
Tools for Authors 18.01.11
Tools for Authors 18.01.11Tools for Authors 18.01.11
Tools for Authors 18.01.11
 
Repositories: Researcher Perspective
Repositories: Researcher PerspectiveRepositories: Researcher Perspective
Repositories: Researcher Perspective
 
ORCID Outreach Working Group
ORCID Outreach Working GroupORCID Outreach Working Group
ORCID Outreach Working Group
 
Helping Researchers Create Scholarly Content
Helping Researchers Create Scholarly ContentHelping Researchers Create Scholarly Content
Helping Researchers Create Scholarly Content
 
ORCID as unique author identifier: what is it good for and should we worry or...
ORCID as unique author identifier: what is it good for and should we worry or...ORCID as unique author identifier: what is it good for and should we worry or...
ORCID as unique author identifier: what is it good for and should we worry or...
 
Trends in Reference Management
Trends in Reference ManagementTrends in Reference Management
Trends in Reference Management
 
Open Access In Medicine
Open Access In MedicineOpen Access In Medicine
Open Access In Medicine
 
Science Publishing - Reward and Reputation
Science Publishing - Reward and ReputationScience Publishing - Reward and Reputation
Science Publishing - Reward and Reputation
 
What is the right reference manager for you?
What is the right reference manager for you?What is the right reference manager for you?
What is the right reference manager for you?
 
Author Id Survey
Author Id SurveyAuthor Id Survey
Author Id Survey
 
Providing public health and medical information to all
Providing public health and medical information to allProviding public health and medical information to all
Providing public health and medical information to all
 

Dernier

Intermediate Accounting, Volume 2, 13th Canadian Edition by Donald E. Kieso t...
Intermediate Accounting, Volume 2, 13th Canadian Edition by Donald E. Kieso t...Intermediate Accounting, Volume 2, 13th Canadian Edition by Donald E. Kieso t...
Intermediate Accounting, Volume 2, 13th Canadian Edition by Donald E. Kieso t...ssuserf63bd7
 
PSCC - Capability Statement Presentation
PSCC - Capability Statement PresentationPSCC - Capability Statement Presentation
PSCC - Capability Statement PresentationAnamaria Contreras
 
Unveiling the Soundscape Music for Psychedelic Experiences
Unveiling the Soundscape Music for Psychedelic ExperiencesUnveiling the Soundscape Music for Psychedelic Experiences
Unveiling the Soundscape Music for Psychedelic ExperiencesDoe Paoro
 
digital marketing , introduction of digital marketing
digital marketing , introduction of digital marketingdigital marketing , introduction of digital marketing
digital marketing , introduction of digital marketingrajputmeenakshi733
 
trending-flavors-and-ingredients-in-salty-snacks-us-2024_Redacted-V2.pdf
trending-flavors-and-ingredients-in-salty-snacks-us-2024_Redacted-V2.pdftrending-flavors-and-ingredients-in-salty-snacks-us-2024_Redacted-V2.pdf
trending-flavors-and-ingredients-in-salty-snacks-us-2024_Redacted-V2.pdfMintel Group
 
Welding Electrode Making Machine By Deccan Dynamics
Welding Electrode Making Machine By Deccan DynamicsWelding Electrode Making Machine By Deccan Dynamics
Welding Electrode Making Machine By Deccan DynamicsIndiaMART InterMESH Limited
 
Send Files | Sendbig.comSend Files | Sendbig.com
Send Files | Sendbig.comSend Files | Sendbig.comSend Files | Sendbig.comSend Files | Sendbig.com
Send Files | Sendbig.comSend Files | Sendbig.comSendBig4
 
Go for Rakhi Bazaar and Pick the Latest Bhaiya Bhabhi Rakhi.pptx
Go for Rakhi Bazaar and Pick the Latest Bhaiya Bhabhi Rakhi.pptxGo for Rakhi Bazaar and Pick the Latest Bhaiya Bhabhi Rakhi.pptx
Go for Rakhi Bazaar and Pick the Latest Bhaiya Bhabhi Rakhi.pptxRakhi Bazaar
 
The McKinsey 7S Framework: A Holistic Approach to Harmonizing All Parts of th...
The McKinsey 7S Framework: A Holistic Approach to Harmonizing All Parts of th...The McKinsey 7S Framework: A Holistic Approach to Harmonizing All Parts of th...
The McKinsey 7S Framework: A Holistic Approach to Harmonizing All Parts of th...Operational Excellence Consulting
 
Onemonitar Android Spy App Features: Explore Advanced Monitoring Capabilities
Onemonitar Android Spy App Features: Explore Advanced Monitoring CapabilitiesOnemonitar Android Spy App Features: Explore Advanced Monitoring Capabilities
Onemonitar Android Spy App Features: Explore Advanced Monitoring CapabilitiesOne Monitar
 
20220816-EthicsGrade_Scorecard-JP_Morgan_Chase-Q2-63_57.pdf
20220816-EthicsGrade_Scorecard-JP_Morgan_Chase-Q2-63_57.pdf20220816-EthicsGrade_Scorecard-JP_Morgan_Chase-Q2-63_57.pdf
20220816-EthicsGrade_Scorecard-JP_Morgan_Chase-Q2-63_57.pdfChris Skinner
 
1911 Gold Corporate Presentation Apr 2024.pdf
1911 Gold Corporate Presentation Apr 2024.pdf1911 Gold Corporate Presentation Apr 2024.pdf
1911 Gold Corporate Presentation Apr 2024.pdfShaun Heinrichs
 
Lucia Ferretti, Lead Business Designer; Matteo Meschini, Business Designer @T...
Lucia Ferretti, Lead Business Designer; Matteo Meschini, Business Designer @T...Lucia Ferretti, Lead Business Designer; Matteo Meschini, Business Designer @T...
Lucia Ferretti, Lead Business Designer; Matteo Meschini, Business Designer @T...Associazione Digital Days
 
Technical Leaders - Working with the Management Team
Technical Leaders - Working with the Management TeamTechnical Leaders - Working with the Management Team
Technical Leaders - Working with the Management TeamArik Fletcher
 
1911 Gold Corporate Presentation Apr 2024.pdf
1911 Gold Corporate Presentation Apr 2024.pdf1911 Gold Corporate Presentation Apr 2024.pdf
1911 Gold Corporate Presentation Apr 2024.pdfShaun Heinrichs
 
GUIDELINES ON USEFUL FORMS IN FREIGHT FORWARDING (F) Danny Diep Toh MBA.pdf
GUIDELINES ON USEFUL FORMS IN FREIGHT FORWARDING (F) Danny Diep Toh MBA.pdfGUIDELINES ON USEFUL FORMS IN FREIGHT FORWARDING (F) Danny Diep Toh MBA.pdf
GUIDELINES ON USEFUL FORMS IN FREIGHT FORWARDING (F) Danny Diep Toh MBA.pdfDanny Diep To
 
The-Ethical-issues-ghhhhhhhhjof-Byjus.pptx
The-Ethical-issues-ghhhhhhhhjof-Byjus.pptxThe-Ethical-issues-ghhhhhhhhjof-Byjus.pptx
The-Ethical-issues-ghhhhhhhhjof-Byjus.pptxmbikashkanyari
 
Excvation Safety for safety officers reference
Excvation Safety for safety officers referenceExcvation Safety for safety officers reference
Excvation Safety for safety officers referencessuser2c065e
 
Fordham -How effective decision-making is within the IT department - Analysis...
Fordham -How effective decision-making is within the IT department - Analysis...Fordham -How effective decision-making is within the IT department - Analysis...
Fordham -How effective decision-making is within the IT department - Analysis...Peter Ward
 

Dernier (20)

Intermediate Accounting, Volume 2, 13th Canadian Edition by Donald E. Kieso t...
Intermediate Accounting, Volume 2, 13th Canadian Edition by Donald E. Kieso t...Intermediate Accounting, Volume 2, 13th Canadian Edition by Donald E. Kieso t...
Intermediate Accounting, Volume 2, 13th Canadian Edition by Donald E. Kieso t...
 
PSCC - Capability Statement Presentation
PSCC - Capability Statement PresentationPSCC - Capability Statement Presentation
PSCC - Capability Statement Presentation
 
Unveiling the Soundscape Music for Psychedelic Experiences
Unveiling the Soundscape Music for Psychedelic ExperiencesUnveiling the Soundscape Music for Psychedelic Experiences
Unveiling the Soundscape Music for Psychedelic Experiences
 
digital marketing , introduction of digital marketing
digital marketing , introduction of digital marketingdigital marketing , introduction of digital marketing
digital marketing , introduction of digital marketing
 
trending-flavors-and-ingredients-in-salty-snacks-us-2024_Redacted-V2.pdf
trending-flavors-and-ingredients-in-salty-snacks-us-2024_Redacted-V2.pdftrending-flavors-and-ingredients-in-salty-snacks-us-2024_Redacted-V2.pdf
trending-flavors-and-ingredients-in-salty-snacks-us-2024_Redacted-V2.pdf
 
Welding Electrode Making Machine By Deccan Dynamics
Welding Electrode Making Machine By Deccan DynamicsWelding Electrode Making Machine By Deccan Dynamics
Welding Electrode Making Machine By Deccan Dynamics
 
Send Files | Sendbig.comSend Files | Sendbig.com
Send Files | Sendbig.comSend Files | Sendbig.comSend Files | Sendbig.comSend Files | Sendbig.com
Send Files | Sendbig.comSend Files | Sendbig.com
 
WAM Corporate Presentation April 12 2024.pdf
WAM Corporate Presentation April 12 2024.pdfWAM Corporate Presentation April 12 2024.pdf
WAM Corporate Presentation April 12 2024.pdf
 
Go for Rakhi Bazaar and Pick the Latest Bhaiya Bhabhi Rakhi.pptx
Go for Rakhi Bazaar and Pick the Latest Bhaiya Bhabhi Rakhi.pptxGo for Rakhi Bazaar and Pick the Latest Bhaiya Bhabhi Rakhi.pptx
Go for Rakhi Bazaar and Pick the Latest Bhaiya Bhabhi Rakhi.pptx
 
The McKinsey 7S Framework: A Holistic Approach to Harmonizing All Parts of th...
The McKinsey 7S Framework: A Holistic Approach to Harmonizing All Parts of th...The McKinsey 7S Framework: A Holistic Approach to Harmonizing All Parts of th...
The McKinsey 7S Framework: A Holistic Approach to Harmonizing All Parts of th...
 
Onemonitar Android Spy App Features: Explore Advanced Monitoring Capabilities
Onemonitar Android Spy App Features: Explore Advanced Monitoring CapabilitiesOnemonitar Android Spy App Features: Explore Advanced Monitoring Capabilities
Onemonitar Android Spy App Features: Explore Advanced Monitoring Capabilities
 
20220816-EthicsGrade_Scorecard-JP_Morgan_Chase-Q2-63_57.pdf
20220816-EthicsGrade_Scorecard-JP_Morgan_Chase-Q2-63_57.pdf20220816-EthicsGrade_Scorecard-JP_Morgan_Chase-Q2-63_57.pdf
20220816-EthicsGrade_Scorecard-JP_Morgan_Chase-Q2-63_57.pdf
 
1911 Gold Corporate Presentation Apr 2024.pdf
1911 Gold Corporate Presentation Apr 2024.pdf1911 Gold Corporate Presentation Apr 2024.pdf
1911 Gold Corporate Presentation Apr 2024.pdf
 
Lucia Ferretti, Lead Business Designer; Matteo Meschini, Business Designer @T...
Lucia Ferretti, Lead Business Designer; Matteo Meschini, Business Designer @T...Lucia Ferretti, Lead Business Designer; Matteo Meschini, Business Designer @T...
Lucia Ferretti, Lead Business Designer; Matteo Meschini, Business Designer @T...
 
Technical Leaders - Working with the Management Team
Technical Leaders - Working with the Management TeamTechnical Leaders - Working with the Management Team
Technical Leaders - Working with the Management Team
 
1911 Gold Corporate Presentation Apr 2024.pdf
1911 Gold Corporate Presentation Apr 2024.pdf1911 Gold Corporate Presentation Apr 2024.pdf
1911 Gold Corporate Presentation Apr 2024.pdf
 
GUIDELINES ON USEFUL FORMS IN FREIGHT FORWARDING (F) Danny Diep Toh MBA.pdf
GUIDELINES ON USEFUL FORMS IN FREIGHT FORWARDING (F) Danny Diep Toh MBA.pdfGUIDELINES ON USEFUL FORMS IN FREIGHT FORWARDING (F) Danny Diep Toh MBA.pdf
GUIDELINES ON USEFUL FORMS IN FREIGHT FORWARDING (F) Danny Diep Toh MBA.pdf
 
The-Ethical-issues-ghhhhhhhhjof-Byjus.pptx
The-Ethical-issues-ghhhhhhhhjof-Byjus.pptxThe-Ethical-issues-ghhhhhhhhjof-Byjus.pptx
The-Ethical-issues-ghhhhhhhhjof-Byjus.pptx
 
Excvation Safety for safety officers reference
Excvation Safety for safety officers referenceExcvation Safety for safety officers reference
Excvation Safety for safety officers reference
 
Fordham -How effective decision-making is within the IT department - Analysis...
Fordham -How effective decision-making is within the IT department - Analysis...Fordham -How effective decision-making is within the IT department - Analysis...
Fordham -How effective decision-making is within the IT department - Analysis...
 

Open Data In Clinical Research

  • 1. Clinical trial registration: a model for basic research? August 17, 2008 Version 1.0 Martin Fenner fenner.martin@mh-hannover.de Hannover Medical School, Germany
  • 2. Rationale for registration of clinical trials • Improve trial participation by patients • Reduce unnecessary duplication of research efforts • Increase opportunities for collaboration • Prevent biased under-reporting or over-reporting of research Krleza-Jeric 2005. doi:10.1136/bmj.330.7497.956